Saturday, 5 September 2026

Indian corporate news, decoded into deal flow

NSE LIVE
NIFTY 50 INDIA VIX
as of
MARKETS
DEAL FLOW
Om Infra FY27 Outlook: ₹2,015 Crore… ▲ Order Book Dixon Technologies: Betting Big on New… ▲ Capex & Future Plan EPL Q1 FY27 Results: Revenue Growth… ▲ Results Weekly Bulk Deals: EPL, Meesho and… ▲ Market News / Economy ATF Price Hike: Will Air Tickets… ▲ Market News / Economy Coca-Cola India Bottler IPO: Hindustan Coca-Cola… ▲ IPOs Anupam Rasayan Secures Six-Year Chemical Supply… ▲ Order Book
Home / Company Results / EPL Q1 FY27 Results: Revenue Growth Guidance Raised to High Teens
RS · Company Results

EPL Q1 FY27 Results: Revenue Growth Guidance Raised to High Teens

EPL Q1 FY27 results have highlighted strong underlying business momentum, with the packaging company reporting robust revenue growth across its key categories and geographies. Management has also raised its revenue growth guidance to the high-teens range for the next few quarters, while retaining its target of around 20% underlying EBITDA margin.

EPL Limited discussed its Q1 FY27 performance during its earnings conference call held on August 11, 2026. The company subsequently filed the conference-call transcript with the stock exchanges on August 28, 2026.

The latest commentary provides investors with important insights into EPL’s growth strategy, Beauty & Cosmetics business, international expansion, cost recovery, Europe margins, and the proposed Indovida merger.

EPL Q1 FY27 Results: Key Highlights

EPL reported a strong quarter despite a volatile global operating environment and higher raw material, freight, and currency-related costs.

Key takeaways from the EPL Q1 FY27 results include:

  • Revenue increased 25.3%
  • Underlying revenue growth was around 20%
  • EBITDA increased 15.2%
  • Reported EBITDA margin stood at 18.8%
  • Underlying EBITDA margin was 19.6%
  • PBT increased 10%
  • PAT declined 1.4%
  • Beauty & Cosmetics growth exceeded 20%
  • Oral Care also delivered more than 20% growth
  • Personal Care & Beyond now represents 54% of the portfolio
  • Sustainable tubes account for 44% of the product mix
  • ROCE stood at 18.5%

Management described the quarter as a record period for underlying revenue growth.

EPL Raises FY27 Revenue Growth Guidance

One of the most important developments from the EPL earnings call was the upgrade in revenue growth guidance.

EPL has raised its revenue growth outlook from early double-digit growth to high-teens growth for the next few quarters.

Management said the upgrade reflects continued momentum in Beauty & Cosmetics, a strong recovery in Oral Care, investments made ahead of growth, and the ramp-up of operations in Thailand.

At the same time, EPL has retained its 20% underlying EBITDA margin target.

This combination of higher revenue growth expectations and stable margin guidance will be an important factor for investors tracking EPL shares.

Beauty & Cosmetics: Major Growth Opportunity for EPL

Beauty & Cosmetics continues to be the biggest structural growth opportunity highlighted by management.

The category grew by more than 20% during Q1 FY27, supported by strong performance across major markets.

EPL believes its current market share of approximately 8% in Beauty & Cosmetics could potentially double to 16% over the next few years.

The company is investing in new technologies, capacity, front-end sales capabilities, printing, decoration and other specialized packaging solutions to capture this opportunity.

For investors, B&C is therefore an important segment to monitor when assessing the future growth potential of EPL.

Personal Care & Beyond Reaches 54% of Portfolio

EPL is gradually increasing its exposure to higher-growth categories.

The company’s Personal Care & Beyond portfolio now accounts for 54% of the overall portfolio.

This shift is strategically important because EPL is attempting to reduce its dependence on mature packaging categories and increase exposure to markets where packaging demand can grow faster.

EPL Q1 FY27 Regional Performance

Growth remained broad-based across EPL’s major geographic regions.

EAP

The EAP region delivered the highest growth during the quarter, with revenue increasing 34.3%.

Americas

The Americas reported 29.4% growth.

Management continues to see opportunities in both Brazil and the United States and is investing in additional capabilities to support future growth.

Europe

Europe delivered 20.2% revenue growth, demonstrating strong demand despite operational challenges.

However, profitability remains below the company’s desired level.

AMESA

The AMESA region reported 17% growth.

The fact that every major region delivered double-digit growth is one of the key positives from the quarter.

Europe Margins Remain a Key Monitorable

While European revenue growth remains strong, EPL continues to work on operational challenges affecting profitability.

Management said these issues have been identified and are receiving increased attention.

EPL is investing in European manufacturing capacity and capabilities, including extruded products, printing and Beauty & Cosmetics-related technologies.

The company operates manufacturing facilities in Poland and Germany and has centralized some capabilities in Poland.

Management expects European margins to progressively improve and move toward the mid-teens range as operational efficiency improves and the benefits of scale begin to emerge.

For investors, EPL Europe margins could therefore become an important trigger for future earnings improvement.

EPL Successfully Recovers Higher Costs Through Pricing

Another significant takeaway from the EPL earnings call was the company’s ability to recover higher costs.

The company faced increases in:

  • Raw material prices
  • Freight costs
  • Currency-related costs

Management said EPL was able to recover the entire cost impact through pricing actions.

This is particularly important because commodity-price volatility has previously affected the company’s profitability.

Management indicated that EPL has strengthened its internal processes for monitoring cost inflation and pricing recovery.

The company believes this should make the business more resilient through future commodity cycles.

Working Capital Increase Driven Mainly by Inventory

EPL’s working capital increased during the quarter, but management clarified that the increase was primarily related to inventories.

Three factors contributed:

  1. Higher inventory valuation due to increased raw material prices.
  2. Additional safety stock was maintained to ensure uninterrupted supplies.
  3. Capital expenditure and investments made ahead of expected growth.

Receivables remained under control, with management stating that receivable aging and quality remained healthy.

This is an important distinction for investors because the working-capital increase was not attributed to deterioration in customer collections.

Thailand Could Become a New Growth Driver

EPL has established operations in Thailand and is beginning to ramp up the business.

Thailand is strategically important because it represents a significant Beauty & Cosmetics market.

The company has already secured wins with multinational customers and expects the Thailand operation to contribute increasingly to growth.

The expansion is part of EPL’s broader strategy of increasing its presence in attractive emerging markets.

Indovida Merger: Strategic Expansion for EPL

The proposed EPL-Indovida merger remains one of the most important strategic developments for the company.

EPL received approval from the Competition Commission of India during the quarter, while the transaction remains subject to the remaining approval process.

Management sees the merger as an important step toward expanding EPL beyond its traditional tube packaging business.

The company’s long-term vision is to become a broader consumer packaging company focused on emerging markets.

Why the Indovida Merger Matters

According to management, the transaction could help EPL:

  • Enter new packaging formats
  • Expand into rigid plastic packaging
  • Access new emerging markets
  • Increase its addressable market
  • Build new capabilities
  • Generate potential synergies

Indovida has a presence in several emerging markets in Southeast Asia and Africa, providing EPL with an opportunity to expand its geographic footprint.

Management also highlighted publicly available Indovida quarterly numbers, including 11% volume growth, 25% revenue growth and 62% EBITDA growth, with EBITDA margin expanding to 27%.

EPL management indicated that the merger could be EPS accretive, although investors will have greater visibility into the combined company’s financial profile after the transaction receives the necessary approvals.

EPL Plans to Move Beyond Tube Packaging

The Indovida transaction is part of a much larger strategic ambition.

Management wants EPL to move beyond its existing tube packaging business and enter additional consumer packaging formats.

The company is actively evaluating acquisition opportunities that could provide:

  • New packaging formats
  • New technologies
  • New capabilities
  • Access to emerging markets
  • Higher growth opportunities
  • Margin expansion potential

This strategy could significantly increase EPL’s addressable market over the long term.

Oral Care Shows Strong Recovery

Oral Care, EPL’s traditional core business, delivered a strong recovery during Q1 FY27.

Management indicated that Oral Care grew by approximately 24% during the quarter.

However, the company cautioned that this unusually high growth rate may not be sustainable every quarter.

The improvement was broad-based across regions, with strong customer engagement and uninterrupted supply helping EPL gain additional wallet share.

EPL Continues Investments Ahead of Growth

EPL is increasing investments in both capital expenditure and operating capabilities.

The company has created a dedicated Beauty & Cosmetics Centre of Excellence in India and reorganized its sales organization into specialized teams.

It is also investing in:

  • New technologies
  • Manufacturing capacity
  • Printing capabilities
  • Embellishments and decorations
  • Beauty & Cosmetics capabilities
  • Sales infrastructure
  • Customer service

Management expects these investments to generate greater operating leverage as revenue scales up.

The company believes that, on a steady-state basis, EBITDA can grow faster than revenue.

Sustainability Remains a Focus

Sustainable packaging is another important part of EPL’s long-term strategy.

The company said 44% of its overall product mix now consists of sustainable tubes.

EPL is continuing to invest in differentiated and sustainable packaging technologies as consumer brands increasingly focus on environmental considerations.

This could provide additional opportunities for the company in the global packaging market.

EPL FY27 Outlook

The management commentary indicates that EPL enters the next phase of FY27 with strong growth momentum.

The major growth drivers include:

Beauty & Cosmetics: Strong demand and significant potential to increase market share.

Oral Care: Strong recovery after a relatively weaker period.

Thailand: New operations beginning to ramp up.

Emerging markets: Continued expansion into high-growth geographies.

New packaging formats: Potential expansion beyond tubes through the Indovida merger and future acquisitions.

Pricing: Continued ability to recover raw material, freight, and currency-related cost increases.

Key Risks for EPL Investors

Despite the positive outlook, investors should also monitor several risks.

Europe profitability: Revenue growth is strong, but operational inefficiencies continue to weigh on margins.

Higher investments: EPL is investing ahead of the growth curve, which could affect near-term profitability and capital efficiency.

Commodity prices: Higher raw material and freight costs remain important variables.

Currency movements: EPL’s global operations expose the company to foreign-exchange fluctuations.

Merger execution: The benefits of the Indovida transaction depend on regulatory approvals, completion, and successful integration.

Growth sustainability: The company has raised its guidance to high-teens growth, making execution against this target an important monitorable.

What Does the EPL Q1 FY27 Update Mean for Investors?

The latest EPL Q1 FY27 results point to a company entering a potentially important growth phase.

The combination of strong Beauty & Cosmetics growth, recovery in Oral Care, expansion in Thailand, and continued international demand provides multiple growth drivers.

More importantly, EPL has raised its revenue growth guidance to the high-teens range while retaining its 20% underlying EBITDA margin target.

The proposed Indovida merger could further expand EPL’s addressable market by taking the company into new packaging formats and emerging markets.

However, investors should watch whether the company’s investments translate into higher margins, stronger capital efficiency, and sustained earnings growth.

EPL Stock: Key Points to Track

For investors following the EPL stock, the key monitorables over the next few quarters will be:

  • Delivery against the high-teens revenue growth guidance
  • Beauty & Cosmetics growth and market-share gains
  • Recovery in Europe margins
  • Thailand business ramp-up
  • EBITDA margin trajectory
  • Working-capital management
  • Capital expenditure and ROCE
  • Progress of the Indovida merger
  • Growth in earnings and EPS

Overall, the Q1 FY27 commentary presents a positive growth outlook for EPL, but execution will remain critical. The company’s ability to sustain high growth while maintaining its underlying margin target will be particularly important in determining the next phase of its earnings trajectory.

Source: EPL Limited Q1 FY27 Earnings Conference Call transcript filed with the stock exchanges on August 28, 2026.

Disclaimer: This article is for informational and educational purposes only and should not be considered investment advice, a recommendation to buy or sell any security, or a guarantee of future returns. Investors should conduct their own research and consult a qualified financial adviser before making investment decisions.